Literature DB >> 28223367

Coordination of Myeloid Differentiation with Reduced Cell Cycle Progression by PU.1 Induction of MicroRNAs Targeting Cell Cycle Regulators and Lipid Anabolism.

Lauren A Solomon1,2, Shreya Podder1,2, Jessica He1,2, Nicholas L Jackson-Chornenki1,2, Kristen Gibson1,2, Rachel G Ziliotto1,2, Jess Rhee1,2, Rodney P DeKoter3,2,4.   

Abstract

During macrophage development, myeloid progenitor cells undergo terminal differentiation coordinated with reduced cell cycle progression. Differentiation of macrophages from myeloid progenitors is accompanied by increased expression of the E26 transformation-specific transcription factor PU.1. Reduced PU.1 expression leads to increased proliferation and impaired differentiation of myeloid progenitor cells. It is not understood how PU.1 coordinates macrophage differentiation with reduced cell cycle progression. In this study, we utilized cultured PU.1-inducible myeloid cells to perform genome-wide chromatin immunoprecipitation sequencing (ChIP-seq) analysis coupled with gene expression analysis to determine targets of PU.1 that may be involved in regulating cell cycle progression. We found that genes encoding cell cycle regulators and enzymes involved in lipid anabolism were directly and inducibly bound by PU.1 although their steady-state mRNA transcript levels were reduced. Inhibition of lipid anabolism was sufficient to reduce cell cycle progression in these cells. Induction of PU.1 reduced expression of E2f1, an important activator of genes involved in cell cycle and lipid anabolism, indirectly through microRNA 223. Next-generation sequencing identified microRNAs validated as targeting cell cycle and lipid anabolism for downregulation. These results suggest that PU.1 coordinates cell cycle progression with differentiation through induction of microRNAs targeting cell cycle regulators and lipid anabolism.
Copyright © 2017 American Society for Microbiology.

Entities:  

Keywords:  E2F1; PU.1; cell cycle; differentiation; lipid synthesis; microRNA; myeloid cells

Mesh:

Substances:

Year:  2017        PMID: 28223367      PMCID: PMC5477546          DOI: 10.1128/MCB.00013-17

Source DB:  PubMed          Journal:  Mol Cell Biol        ISSN: 0270-7306            Impact factor:   4.272


  49 in total

1.  E2f1-3 are critical for myeloid development.

Authors:  Prashant Trikha; Nidhi Sharma; Rene Opavsky; Andres Reyes; Clarissa Pena; Michael C Ostrowski; Martine F Roussel; Gustavo Leone
Journal:  J Biol Chem       Date:  2010-11-28       Impact factor: 5.157

2.  miR-342-3p regulates MYC transcriptional activity via direct repression of E2F1 in human lung cancer.

Authors:  Mei Chee Tai; Taisuke Kajino; Masahiro Nakatochi; Chinatsu Arima; Yukako Shimada; Motoshi Suzuki; Hiroyuki Miyoshi; Yasushi Yatabe; Kiyoshi Yanagisawa; Takashi Takahashi
Journal:  Carcinogenesis       Date:  2015-10-18       Impact factor: 4.944

Review 3.  Concise review: Exploring miRNAs--toward a better understanding of hematopoiesis.

Authors:  Seok-Ho Hong; Kye-Seong Kim; Il-Hoan Oh
Journal:  Stem Cells       Date:  2015-01       Impact factor: 6.277

Review 4.  The development and maintenance of resident macrophages.

Authors:  Elisa Gomez Perdiguero; Frederic Geissmann
Journal:  Nat Immunol       Date:  2016-01       Impact factor: 25.606

5.  ATP citrate lyase inhibition can suppress tumor cell growth.

Authors:  Georgia Hatzivassiliou; Fangping Zhao; Daniel E Bauer; Charalambos Andreadis; Anthony N Shaw; Dashyant Dhanak; Sunil R Hingorani; David A Tuveson; Craig B Thompson
Journal:  Cancer Cell       Date:  2005-10       Impact factor: 31.743

6.  PU.1 is a suppressor of myeloid leukemia, inactivated in mice by gene deletion and mutation of its DNA binding domain.

Authors:  Wendy D Cook; Benjamin J McCaw; Christopher Herring; Deborah L John; Simon J Foote; Stephen L Nutt; Jerry M Adams
Journal:  Blood       Date:  2004-08-10       Impact factor: 22.113

7.  Reduction in PU.1 activity results in a block to B-cell development, abnormal myeloid proliferation, and neonatal lethality.

Authors:  Isaac B Houston; Meghana B Kamath; Brock L Schweitzer; Timothy M Chlon; Rodney P DeKoter
Journal:  Exp Hematol       Date:  2007-07       Impact factor: 3.084

8.  Genome-wide analysis of transcription factor E2F1 mutant proteins reveals that N- and C-terminal protein interaction domains do not participate in targeting E2F1 to the human genome.

Authors:  Alina R Cao; Roman Rabinovich; Maoxiong Xu; Xiaoqin Xu; Victor X Jin; Peggy J Farnham
Journal:  J Biol Chem       Date:  2011-02-10       Impact factor: 5.157

9.  miRGate: a curated database of human, mouse and rat miRNA-mRNA targets.

Authors:  Eduardo Andrés-León; Daniel González Peña; Gonzalo Gómez-López; David G Pisano
Journal:  Database (Oxford)       Date:  2015-04-08       Impact factor: 3.451

10.  Sustained PU.1 levels balance cell-cycle regulators to prevent exhaustion of adult hematopoietic stem cells.

Authors:  Philipp B Staber; Pu Zhang; Min Ye; Robert S Welner; César Nombela-Arrieta; Christian Bach; Marc Kerenyi; Boris A Bartholdy; Hong Zhang; Meritxell Alberich-Jordà; Sanghoon Lee; Henry Yang; Felicia Ng; Junyan Zhang; Mathias Leddin; Leslie E Silberstein; Gerald Hoefler; Stuart H Orkin; Berthold Göttgens; Frank Rosenbauer; Gang Huang; Daniel G Tenen
Journal:  Mol Cell       Date:  2013-02-08       Impact factor: 17.970

View more
  4 in total

1.  ACLY is the novel signaling target of PIP2/PIP3 and Lyn in acute myeloid leukemia.

Authors:  Johnvesly Basappa; Mevlut Citir; Qian Zhang; Hong Y Wang; Xiaobin Liu; Olga Melnikov; Hafiz Yahya; Frank Stein; Rainer Muller; Alexis Traynor-Kaplan; Carsten Schultz; Mariusz A Wasik; Andrzej Ptasznik
Journal:  Heliyon       Date:  2020-05-07

2.  Cell cycle exit during bortezomib-induced osteogenic differentiation of mesenchymal stem cells was mediated by Xbp1s-upregulated p21Cip1 and p27Kip1.

Authors:  Dan Zhang; Rong Fan; Li Lei; Lei Lei; Yanmeng Wang; Nan Lv; Ping Chen; Ramone A Williamson; Baiyan Wang; Jinsong Hu
Journal:  J Cell Mol Med       Date:  2020-07-06       Impact factor: 5.310

3.  CRISPR screens for lipid regulators reveal a role for ER-bound SNX13 in lysosomal cholesterol export.

Authors:  Bikal R Sharma; Sydney R Vaughn; Albert Lu; Frank Hsieh; Carlos Enrich; Suzanne R Pfeffer
Journal:  J Cell Biol       Date:  2021-12-22       Impact factor: 8.077

Review 4.  The role of a key transcription factor PU.1 in autoimmune diseases.

Authors:  Yilong Fang; Weile Chen; Zhe Li; Yu Chen; Xuming Wu; Xiangling Zhu; Huihui Wang; Xiaochun Chen; Qiuni Liang; Jinghua Huang; Xintong Han; Wenming Hong; Xinming Wang; Wei Wei; Zhiying Yu; Jiajie Tu
Journal:  Front Immunol       Date:  2022-09-29       Impact factor: 8.786

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.